Stromal Cells and Tumor Milieu: PDGF et al.

Part of the Cancer Genetics book series (CANGENETICS)


Initiation of the desmoplastic reaction associated with cancer depends on PDGF (Shao et al., 2000). Similarly, PDGF is one of the most potent chemoattractants and activators of fibroblasts, stimulating their differentiation into myofibroblasts, which represent a prominent stromal cell type in carcinomas.  Although a translocation resulting in a fusion product between PDGF and COL1A (which encodes type I collagen) is associated with dermatofibrosarcoma protuberans, no mutations in either members of the PDGF family or their receptors have been identified in carcinomas. However, aberrant PDGF signaling has been observed in carcinomas where it promotes desmoplasia and tumor progression (reviewed by Tejada et al.,2006), due to increased secretion of PDGF by tumor cells and/or higher levels of expression of PDGF receptors on stromal fibroblasts (Ebert et al., 1995). In the following chapter, we discuss the fibroblast-to-myofibroblast transition and how stromal cells may impact tumor evolution.


Stromal Cell Tumor Microenvironment Idiopathic Pulmonary Fibrosis Stress Fiber Stromal Fibroblast 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Acharya PS, Zukas A, Chandan V, Katzenstein AL and Puré E (2006) Fibroblast Activation Protein: a Serine Protease Expressed at the Remodeling Interface in Idiopathic Pulmonary Fibrosis. Hum Pathol 37: 352–360.PubMedCrossRefGoogle Scholar
  2. Anderberg C, Li H, Fredriksson L, Andrae J, Betsholtz C, Li X, Eriksson U and Pietras K (2009) Paracrine Signaling by Platelet-Derived Growth Factor-CC Promotes Tumor Growth by Recruitment of Cancer-Associated Fibroblasts. Cancer Res 69: 369–378.PubMedCrossRefGoogle Scholar
  3. Bar J, Feniger-Barish R, Lukashcguk N, Shaham H, Moskovits N, Goldfinger N, Simansky D, Perlman M, Papa M, Yosepovitch A, Rechavi G, Rotter V and Oren M (2008) Cancer cells suppress p53 in adjacent fibroblasts. Oncogene 28: 933–936.PubMedCrossRefGoogle Scholar
  4. Bauer S, Jendro M, Wadle A, Kleber S, Stenner F, Dinser R, Reich A, Faccin E, Godde S, Dinges H, Muller-Ladner U and Renner C (2006) Fibroblast Activation Protein Is Expressed by Rheumatoid Myofibroblast-Like Synoviocytes. Arthritis Res Ther 8: R171.PubMedCrossRefGoogle Scholar
  5. Bhowmick NA and Moses HL (2005) Tumor-Stroma Interactions. Curr Opin Genet Dev 15: 97–101.PubMedCrossRefGoogle Scholar
  6. Bignotti E, Tassi RA, Calza S, Ravaggi A, Bandiera E, Rossi E, Donzelli C, Pasinetti B, Pecorelli S and Santin A D (2007) Gene Expression Profile of Ovarian Serous Papillary Carcinomas: Identification of Metastasis-Associated Genes. Am J Obstet Gynecol 196: 245.PubMedCrossRefGoogle Scholar
  7. Chen WT and Kelly T (2003) Seprase Complexes in Cellular Invasiveness. Cancer Metastasis Rev 22: 259–269.PubMedCrossRefGoogle Scholar
  8. Chen ML, Pittet MJ, Gorelik L, Flavell RA, Weissleder R, von Boehmer H and Khazaie K (2005) Regulatory T Cells Suppress Tumor-Specific CD8 T Cell Cytotoxicity Through TGFβ Signals in Vivo. Proc Natl Acad Sci 102: 419–424.PubMedCrossRefGoogle Scholar
  9. Chen ST, Pan TL, Juan HF, Chen TY, Lin YS and Huang CM (2008) Breast Tumor Microenvironment: Proteomics Highlights the Treatments Targeting Secretome. J Proteome Res 7: 1379–1387.PubMedCrossRefGoogle Scholar
  10. Cheng JD, Dunbrack RL Jr, Valianou M, Rogatko A, Alpaugh RK and Weiner LM (2002) Promotion of Tumor Growth by Murine Fibroblast Activation Protein, a Serine Protease, in an Animal Model. Cancer Res 62: 4767–4772.PubMedGoogle Scholar
  11. Cheng JD, Valianou M, Canutescu AA, Jaffe EK, Lee HO, Wang H, Lai JH, Bachovchin WW and Weiner LM (2005a) Abrogation of Fibroblast Activation Protein Enzymatic Activity Attenuates Tumor Growth. Mol Cancer Ther 4: 351–360.PubMedCrossRefGoogle Scholar
  12. Cheng N, Bhowmick NA, Chytil A, Gorksa AE, Brown KA, Muraoka R, Arteaga CL, Neilson EG, Hayward SW and Moses HL (2005b) Loss of TGF-[Beta] Type II Receptor in Fibroblasts Promotes Mammary Carcinoma Growth and Invasion Through Upregulation of TGF-[Alpha]-, MSP- and HGF-Mediated Signaling Networks. Oncogene 24: 5053–5068.PubMedCrossRefGoogle Scholar
  13. Christian S, Winkler R, Helfrich I, Boos AM, Besemfelder E, Schadendorf D and Augustin HG (2008) Endosialin (Tem1) Is a Marker of Tumor-Associated Myofibroblasts and Tumor Vessel-Associated Mural Cells. Am J Pathol 172: 486–494.PubMedCrossRefGoogle Scholar
  14. Darby IA and Hewitson TD (2007) Fibroblast Differentiation in Wound Healing and Fibrosis, in International Review of Cytology, A Survey of Cell Biology Kwang WJ ed. Academic Press, pp 143–179.Google Scholar
  15. De Wever O and Mareel M (2003) Role of Tissue Stroma in Cancer Cell Invasion. J Pathol 200: 429–447.PubMedCrossRefGoogle Scholar
  16. Duffy MJ, McGowan PM and Gallagher WM (2008) Cancer Invasion and Metastasis: Changing Views. J Pathol 214: 283–293.PubMedCrossRefGoogle Scholar
  17. Ebert M, Yokoyama M, Friess H, Kobrin MS, Buchler MW and Korc M (1995) Induction of Platelet-Derived Growth Factor A and B Chains and Over-expression of Their Receptors in Human Pancreatic Cancers. Int J Cancer 62: 529–535.PubMedCrossRefGoogle Scholar
  18. Egeblad M, Littlepage LE and Werb Z (2005) The Fibroblastic Coconspirator in Cancer Progression. Cold Spring Harb Symp Quant Biol 70: 383–388.PubMedCrossRefGoogle Scholar
  19. Elenbaas B and Weinberg RA (2001) Heterotypic Signaling Between Epithelial Tumor Cells and Fibroblasts in Carcinoma Formation. Exp Cell Res 264: 169–184.PubMedCrossRefGoogle Scholar
  20. Fukino K, Shen L Matsumoto S, Morrison CD, Mutter GL and Eng C (2004) Combined Total Genome Loss of Heterozygosity Scan of Breast Cancer Stroma and Epithelium Reveals Multiplicity of Stromal Targets. Cancer Res 64: 7231–7236.PubMedCrossRefGoogle Scholar
  21. Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall J F, Harrington K and Sahai E (2007) Fibroblast-Led Collective Invasion of Carcinoma Cells with Differing Roles for RhoGTPases in Leading and Following Cells. Nat Cell Biol 9: 1392–1400.PubMedCrossRefGoogle Scholar
  22. Hanahan D and Weinberg RA (2000) The Hallmarks of Cancer. Cell 100: 57–70.PubMedCrossRefGoogle Scholar
  23. Hill R, Song Y, Cardiff RD and Van Dyke T (2005) Selective Evolution of Stromal Mesenchyme With P53 Loss in Response to Epithelial Tumorigenesis. Cell 123: 1001–1011.PubMedCrossRefGoogle Scholar
  24. Hinz B, Celetta G, Tomasek JJ, Gabbiani G and Chaponnier C (2001) Alpha-smooth Muscle Actin Expression Upregulates Fibroblast Contractile Activity. Mol Biol Cell 12: 2730–2741.PubMedGoogle Scholar
  25. Hu L et al. (2004) Association of vimentin overexpression and hepatocellular carcinoma metastasis. Oncogene 23: 298–302.Google Scholar
  26. Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB and Logsdon CD (2008) Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression . Cancer Res 68: 918–926.PubMedCrossRefGoogle Scholar
  27. Ji H et al. (2007) LKB1 Modulates Lung Cancer Differentiation and Metastasis. Nature 448: 807–811.PubMedCrossRefGoogle Scholar
  28. Kiaris H, Chatzistamou I, Trimis G, Frangou-Plemmenou M, Pafiti-Kondi A and Kalofoutis A (2005) Evidence for Nonautonomous Effect of P53 Tumor Suppressor in Carcinogenesis. Cancer Res 65: 1627–1630.PubMedCrossRefGoogle Scholar
  29. Koyama H, Kobayashi N, Harada M, Takeoka M, Kawai Y, Sano K, Fujimori M, Amano J, Ohhashi T, Kannagi R , Kimata K, Taniguchi S and Itano N (2008) Significance of Tumor-Associated Stroma in Promotion of Intratumoral Lymphangiogenesis: Pivotal Role of a Hyaluronan-Rich Tumor Microenvironment. Am J Pathol 172: 179–193.PubMedCrossRefGoogle Scholar
  30. Krtolica A, Parrinello S, Lockett S, Desprez PY and Campisi J (2001) Senescent Fibroblasts Promote Epithelial Cell Growth and Tumorigenesis: A Link Between Cancer and Aging. Proc Natl Acad Sci 98: 12072–12077.PubMedCrossRefGoogle Scholar
  31. Kurose K, Hoshaw-Woodard S, Adeyinka A, Lemeshow S, Watson PH and Eng PH (2001) Genetic Model of Multi-step Breast Carcinogenesis Involving the Epithelium and Stroma: Clues to Tumour-Microenvironment Interactions. Hum Mol Genet 10: 1907–1913.PubMedCrossRefGoogle Scholar
  32. Lafkas D, Trimis G, Papavassiliou AG and Kiaris H (2008) P53 Mutations in Stromal Fibroblasts Sensitize Tumors Against Chemotherapy. Int J Cancer 123: 967–971.PubMedCrossRefGoogle Scholar
  33. Larsen K, Macleod D, Nihlberg K, Gurcan E, Bjermer L , Marko-Varga G and Westergren-Thorsson G (2006) Specific Haptoglobin Expression in Bronchoalveolar Lavage During Differentiation of Circulating Fibroblast Progenitor Cells in Mild Asthma. J Proteome Res 5: 1479–1483.PubMedCrossRefGoogle Scholar
  34. Lawler J and Detmar M (2004) Tumor Progression: The Effects of Thrombospondin-1 and -2. Int J Biochem Cell Biol 36: 1038–1045.PubMedCrossRefGoogle Scholar
  35. Levy ML, McCaughan GW, Abbott CA, Park JE, Cunningham AM, Müller E, Rettig WJ and Gorrell MD (2002) Fibroblast Activation Protein: A Cell Surface Dipeptidyl Peptidase and Gelatinase Expressed by Stellate Cells at the Tissue Remodelling Interface in Human Cirrhosis. Hepatol 29: 1768–1778.CrossRefGoogle Scholar
  36. Liang P, Hong JW, Ubukata H, Liu G, Katano M, Motohashi G, Kasuga T, Watanabe Y, Nakada I and Tabuchi T (2005) Myofibroblasts Correlate With Lymphatic Microvessel Density and Lymph Node Metastasis in Early-Stage Invasive Colorectal Carcinoma. Anticancer Res 25: 2705–2712.PubMedGoogle Scholar
  37. Maffini MV, Soto AM, Calabro JM, Ucci AA and Sonnenschein C (2003) The Stroma as a Crucial Target in Rat Mammary gland Carcinogenesis. J Cell Sci 117:1495–1502.CrossRefGoogle Scholar
  38. Matsumoto N, Yoshida T, Yamashita K, Numata Y and Okayasu I (2003) Possible Alternative Carcinogenesis Pathway Featuring Microsatellite Instability in Colorectal Cancer Stroma. Br J Cancer 89: 707–712.PubMedCrossRefGoogle Scholar
  39. Matziari M, Dive V and Yiotakis A (2007) Matrix Metalloproteinase 11 (MMP-11; Stromelysin-3) and Synthetic Inhibitors. Med Res Rev 27: 528–552.PubMedCrossRefGoogle Scholar
  40. Moinfar F, Man YG, Arnould L, Bratthauer GL, Ratschek M and Tavassoli FA (2000) Concurrent and Independent Genetic Alterations in the Stromal and Epithelial Cells of Mammary Carcinoma: Implications for Tumorigenesis. Cancer Res 60: 2562–2566.PubMedGoogle Scholar
  41. Mueller MM and Fusenig NE (2004) Friends or Foes – Bipolar Effects of the Tumour Stroma in Cancer. Nat Rev Cancer 4: 839–849.PubMedCrossRefGoogle Scholar
  42. Nicco C, Laurent A, Chereau C, Weill B and Batteux F (2005) Differential Modulation of Normal and Tumor Cell Proliferation by Reactive Oxygen Species. Biomed Pharmacother 59: 169–174.PubMedCrossRefGoogle Scholar
  43. Niedermeyer J, Scanlan MJ, Garin-Chesa P, Daiber C, Fiebig HH, Old LJ, Rettig WJ and Schnapp A (1997) Mouse Fibroblast Activation Protein: Molecular Cloning, Alternative Splicing and Expression in the Reactive Stroma of Epithelial Cancers. Int J Cancer 71: 383–389.PubMedCrossRefGoogle Scholar
  44. Noel A, Jost M and Maquoi E (2008) Matrix Metalloproteinases at Cancer Tumor-Host Interface. Semin Cell Dev Biol 19: 52–60.PubMedCrossRefGoogle Scholar
  45. Orend G and Chiquet-Ehrismann R (2006) Tenascin-C Induced Signaling in Cancer. Cancer Lett 244: 143–163.PubMedCrossRefGoogle Scholar
  46. Ostman A (2004) PDGF Receptors-Mediators of Autocrine Tumor Growth and Regulators of Tumor Vasculature and Stroma. Cytokine Growth Factor Rev 15: 275–286.PubMedCrossRefGoogle Scholar
  47. Park JE, Lenter MC, Zimmerman RA, Garin-Chesa P, Old LJ and Rettig WJ (1999) Fibroblast Activation Protein, a Dual Specificity Serine Protease Expressed in Reactive Human Tumor Stromal Fibroblasts. Proc Natl Acad Sci U S A 274: 36505–36512.Google Scholar
  48. Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S and Campisi J (2003) Oxygen Sensitivity Severely Limits the Replicative Lifespan of Murine Fibroblasts. Nat Cell Biol 5: 741–747.PubMedCrossRefGoogle Scholar
  49. Paterson RF, Ulbright TM, MacLennan GT, Zhang S, Pan CX, Sweeney CJ, Moore CR, Foster RS, Koch MO, Eble JN and Cheng L (2003) Molecular Genetic Alterations in the Laser-Capture-Microdissected Stroma Adjacent to Bladder Carcinoma. Cancer 98: 1830–1836.PubMedCrossRefGoogle Scholar
  50. Pazzolli E, Luo X, Brehm S, Carbery K, Chung J-J, Prior JL, Doherty J, Demehri S, Salavaggione L, Piwnica-Worms D and Stewart SA (2009) Senescent Stromal-Derived Osteopontin Promotes Preneoplastic Cell Growth. Cancer Res 69: 1230–1239.CrossRefGoogle Scholar
  51. Pelham RJ, Rodgers L, Hall I, Lucito R, Nguyen KCQ , Navin N, Hicks J, Mu D, Powers S, Wigler M and Botstein D (2006) Identification of Alterations in DNA Copy Number in Host Stromal Cells During Tumor Progression. Proc Natl Acad Sci 103: 19848–19853.PubMedCrossRefGoogle Scholar
  52. Pietras K, Sjoblom T, Rubin K, Heldin C-H and Ostman A (2003) PDGF Receptors as Cancer Drug Targets. Cancer Cell 3: 439–443.PubMedCrossRefGoogle Scholar
  53. Radisky ES and Radisky DC (2007) Stromal Induction of Breast Cancer: Inflammation and Invasion. Rev Endocr Metab Discord 8: 279–287.CrossRefGoogle Scholar
  54. Radisky DC, Kenny PA and Bissell MJ (2007) Fibrosis and Cancer: Do Myofibroblasts Come Also From Epithelial Cells Via EMT? J Cell Biochem 101: 830–839.PubMedCrossRefGoogle Scholar
  55. Ramaekers FC, Haag D, Kant A, Moesker O, Jap PH and Voojis GP (1983) Coexpression of kertain- and vimentin-type intermediate filaments in human metastatic carcinoma cells. Proc. Natl. Acad. Sci. 80: 2618–2622.Google Scholar
  56. Ramirez-Montagut T, Blachere N E, Sviderskaya E V, Bennett D C, Rettig W J, Garin-Chesa P and Houghton AN (2004) FAPalpha, a Surface Peptidase Expressed During Wound Healing, Is a Tumor Suppressor. Oncogene 23: 5435–5446.PubMedCrossRefGoogle Scholar
  57. Sanchez-Cespedes M, Parrella O, Esteller M, Nomoto S, Trink B, Engles JM, Westra WH, Herman JG and Sidransky D (2002) Inactivation of LKB1/STK11 Is a Common Event in Adenocarcinomas of the Lung. Cancer Res 62: 3659–3662.PubMedGoogle Scholar
  58. Schurch W, Seemayer T A and Legace R (1981) Stromal Myofibroblasts in Primary Invasive and Metastatic Carcinomas. A Combined Immunological, Light and Electron Microscopic Study. Virchows Arch A Pathol Anat Histol 391: 125–139.PubMedCrossRefGoogle Scholar
  59. Shao ZM, Nguyen M and Barsky SH (2000) Human Breast Carcinoma Desmoplasia Is PDGF Initiated. Oncogene 19: 4337–4345.PubMedCrossRefGoogle Scholar
  60. Sid B, Sartelet H, Bellon G, El Btaouri H, Rath G, Delorme N, Haye B and Martiny L (2004) Thrombospondin 1: A Multifunctional Protein Implicated in the Regulation of Tumor Growth. Crit Rev Oncol Hematol 49: 245–258.PubMedCrossRefGoogle Scholar
  61. Silzle T, Randolph GJ, Kreutz M and Kunz-Schughart LA (2004) The Fibroblast: Sentinel Cell and Local Immune Modulator in Tumor Tissue. Int J Cancer 108: 173–180.PubMedCrossRefGoogle Scholar
  62. Speroni L, de los Angeles Bustuoabad V, Gasparri J, Chiaramoni NS, Taira MC, Ruggiero RA and del Valle Alonso S (2009) Alternative Site of Implantation Affects Tumor Malignancy and Metastatic Potential in Mice. Cancer Biol Ther 8: 1–5.CrossRefGoogle Scholar
  63. Stojic J, Hagemann C, Haas S, Herbold C, Kuhnel S, Gerngras S, Roggendorf W, Roosen K and Vince GH (2008) Expression of Matrix Metalloproteinases MMP-1, MMP-11 and MMP-19 Is Correlated With the WHO-Grading of Human Malignant Gliomas. Nerosci Res 60: 40–49.CrossRefGoogle Scholar
  64. Storz P (2005) Reactive Oxygen Species in Tumor Progression. Front Biosci 10: 1881–1896.PubMedCrossRefGoogle Scholar
  65. Tejada ML, Yu L, Dong J, Jung K, Meng G, Peale FV, Frantz GD, Hall L, Liang X, Gerber HP, and Ferrara N (2006) Tumor-Driven Paracrine Platelet-Derived Growth Factor Receptor Alpha Signaling Is a Key Determinant of Stromal Cell Recruitment in a Model of Human Lung Carcinoma. Clin Cancer Res 12:2676–2688.PubMedCrossRefGoogle Scholar
  66. Tlsty TD and Hein PW (2001) Know Thy Neighbor: Stromal Cells Can Contribute Oncogenic Signals. Curr Opin Genet Dev 11: 54–59.PubMedCrossRefGoogle Scholar
  67. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C and Brown RA (2002) Myofibroblasts and Mechano-Regulation of Connective Tissue Remodelling. Nat Rev Mol Cell Biol 3: 349–363.PubMedCrossRefGoogle Scholar
  68. Trebaul A, Chan EK and Midwood KS (2007) Regulation of Fibroblast Migration by Tenascin-C. Biochem Soc Trans 35: 695–697.PubMedCrossRefGoogle Scholar
  69. Trimboli AJ, Fukino K, de Bruin A, Wei G, Shen L, Tanner SM, Creasap N, Rosol TJ, Robinson ML, Eng C, Ostrowski MC and Leone G (2008) Direct Evidence for Epithelial-Mesenchymal Transitions in Breast Cancer. Cancer Res 68: 937–945.PubMedCrossRefGoogle Scholar
  70. Tsai KK, Chuang EY, Little JB and Yuan ZM (2005) Cellular Mechanisms for Low-Dose Ionizing Radiation-Induced Perturbation of the Breast Tissue Microenvironment. Cancer Res 65: 6734–6744.PubMedCrossRefGoogle Scholar
  71. Tuhkanen H, Anttila M, Kosma VM, Yla-Herttuala S, Heinonen S, Kuronen A, Juhola M, Tammi R and Mannermaa A (2004) Genetic Alterations in the Peritumoral Stromal Cells of Malignant and Borderline Epithelial Ovarian Tumors as Indicated by Allelic Imbalance on Chromosome 3p. Int J Cancer 109: 247–252.PubMedCrossRefGoogle Scholar
  72. Vaahtomeri K, Bentela E, Laajanen K, Katajisto P, Wipff P-J, Hinz B, Vallenius T, Tiainen M and Makela TP (2008). Lkb1 Is Required for TGFβ-Mediated Myofibroblast Differentiation. J Cell Sci 121: 3531–3540.PubMedCrossRefGoogle Scholar
  73. Walter K, Omura N, Hong SM, Griffith M and Goggins M (2008) Pancreatic Cancer Associated Fibroblasts Display Normal Allelotypes. Cancer Biol Ther 7: 882–888.PubMedCrossRefGoogle Scholar
  74. Webber J, Meran S, Steadman R and Phillips A (2009). Hyaluronan Orchestrates TGF-β1 Dependent Maintenance of Myofibroblast Phenotype. J Biol Chem 284: 9083–9092.Google Scholar
  75. Wernert N, Locherbach C, Wellmann A, Behrens P and Hugel A (2001) Presence of Genetic Alterations in Microdissected Stroma of Human Colon and Breast Cancers. Anticancer Res 21: 2259–2264.PubMedGoogle Scholar
  76. Wicki A and Christofori G (2007) The Potential Role of Podoplanin in Tumour Invasion. Br J Cancer 96: 1–5.PubMedCrossRefGoogle Scholar
  77. Wipff PJ, Rifkin DB, Meister JJ and Hinz B (2007) Myofibroblast Contraction Activates Latent TGF- 1 From the Extracellular Matrix. J Cell Biol 179: 1311–1323.PubMedCrossRefGoogle Scholar
  78. Zhuang ZG, Di GH, Shen ZZ, Ding J and Shao ZM (2006) Enhanced Expression of LKB1 in Breast Cancer Cells Attenuates Angiogenesis, Invasion, and Metastasic Potential. Mol Cancer Res 4: 843–849.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.The Wistar InstitutePhiladelphiaUSA

Personalised recommendations